Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-478
Closed -$22.9K 10956
2025
Q3
$22.9K Sell
478
-460
-49% -$20K ﹤0.01% 8066
2025
Q2
$29.3K Buy
938
+201
+27% +$5.94K ﹤0.01% 8176
2025
Q1
$22.1K Buy
737
+671
+1,017% +$19.1K ﹤0.01% 8160
2024
Q4
$1.67K Buy
66
+62
+1,550% +$1.95K ﹤0.01% 9186
2024
Q3
$124 Sell
4
-159
-98% -$4.77K ﹤0.01% 9136
2024
Q2
$5.39K Buy
+163
New +$5.63K ﹤0.01% 8000
2024
Q1
Sell
-3
Closed -$112 9791
2023
Q4
$112 Buy
+3
New +$129 ﹤0.01% 8910
2023
Q3
Sell
-4
Closed -$333 9800
2023
Q2
$333 Sell
4
-143
-97% -$6.19K ﹤0.01% 8300
2023
Q1
$5.17K Buy
147
+91
+163% +$3.35K ﹤0.01% 8073
2022
Q4
$2.16K Sell
56
-253
-82% -$10.4K ﹤0.01% 9724
2022
Q3
$13K Buy
+309
New +$18.9K ﹤0.01% 8051

Other funds holding NCRA

UBS Group's NCRA Position: Q4 2025 in Review

UBS Group sold out of Nocera (NCRA) in Q4 2025, closing a stake of 478 shares — an estimated $22.9K sold.

UBS Group first reported a position in NCRA in Q3 2022 and held it in 11 quarters. The position peaked at $29.3K in Q2 2025. 8 funds tracked by Wall St. Rank hold NCRA as of Q4 2025.

  • UBS Group reported no remaining Nocera position as of Q4 2025 after selling out during the quarter.
  • UBS Group sold 478 Nocera shares in Q4 2025, an estimated $22.9K.
  • UBS Group first reported a position in Nocera in Q3 2022 and held it in 11 quarters.
  • UBS Group's Nocera position peaked at $29.3K in Q2 2025.
  • 8 funds tracked by Wall St. Rank held Nocera as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.